Ignite Creation Date:
2024-05-06 @ 4:05 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04863079
Status:
UNKNOWN
Last Update Posted:
2021-04-28
First Post:
2021-04-26
Brief Title:
Pembrolizumab in Post Radical Operation ESCC Patients With Lymph Node Positive KEYSTONE-004
Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Organization:
Tianjin Medical University Cancer Institute and Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Pembrolizumab |
| ESCC |
| Adjuvant Treatment |
| Lymph Node Positive |
Keywords: